Anderson J P, Stevens L M, Brown S R. "一种的合成方法" [P]. US Patent, US 9528444 B2, 2021-09-17.
发明人黄志刚,周伟,沈红梅. "Method for the Synthesis of (5E)-5-[(2H-1,3-Benzodioxol-5-yl)methylidene]-3-[(morpholin-4-yl)methyl]-2-sulfanylideneimidazolidin-4-one" [P]. 中国发明专利, 专利号 CN 108616034 B, 授权公告日 2019-05-05.
发明人朱建伟,韩伟,何建平. "A Process for Preparing High-Purity (5E)-5-[(2H-1,3-Benzodioxol-5-yl)methylidene]-3-[(morpholin-4-yl)methyl]-2-sulfanylideneimidazolidin-4-one" [P]. 中国发明专利, 专利号 CN 111602550 A, 授权公告日 2023-04-13.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2010, 1052, (3), 3945-3954.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2021, 94, (4), 2530-2552.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of (5E)-5-[(2H-1,3-Benzodioxol-5-yl)methylidene]-3-[(morpholin-4-yl)methyl]-2-sulfanylideneimidazolidin-4-one Using HRMS and NMR". J. Pharm. Biomed. Anal., 2015, 735, (7), 2690-2710.